Background Two recent studies, a cohort study from Denmark, and a case-control study from
The Netherlands, have reported increased risks of venous thromboembolism (VTE) among …

Objective To assess the risk of venous thromboembolism from use of combined oral
contraceptives according to progestogen type and oestrogen dose. Design National …

Background Two studies recently published in the British Medical Journal, a retrospective
cohort study using information from the Danish registries1 and the MEGA case-control study …

Controversy exists regarding whether oral contraceptives (OCs) containing desogestrel and
gestodene are associated with an increased risk of venous thromboembolism (VTE) versus …

Background Four studies published since December, 1995, reported that the incidence of
venous thromboembolism (VTE) was higher in women who used oral contraceptives (OCs) …

Previous discussions have indicated that the small increases of risk of venous
thromboembolism (VTE) associated with newer combined oral contraceptives (third …

Background. New studies about the influence of hormonal contraception on the risk of
venous thromboembolism (VTE) have been published. Aim. To evaluate new …

Abstract In October 1995 the Committee on Safety of Medicines advised UK doctors and
pharmacists that oral contraceptives containing desogestrel and gestodene were associated …

Objective: Three research articles published in late 1995 and early 1996 suggested that oral
contraceptives containing either of the newer progestogens (gestodene or desogestrel) …

Objective To assess the risk of venous thrombosis in current users of different types of
hormonal contraception, focusing on regimen, oestrogen dose, type of progestogen, and …